Australia
Australia's Genesis makes biolabs investment
Genesis Capital, a mid-market Australian private equity firm specialising in healthcare, has acquired a majority stake in Crux Biolabs, a contract research organisation (CRO) based in the Melbourne suburbs.
Adamantem to carve out cardiology unit from Australia's GenesisCare
Adamantem Capital has agreed to acquire Australia’s largest cardiology services provider through as a carve-out from KKR-backed healthcare giant GenesisCare.
Australia hydrogen player gets $29m Series A
Australia’s Virescent Ventures, a VC firm spun out earlier this year from Clean Energy Finance Corporation (CEFC), has led a AUD 40m (USD 29m) Series A round for local hydrogen energy start-up Hysata.
Skip Capital, Stonepeak pursue Australia's Genex Power
Australia-listed renewable energy producer Genex Power has rejected an initial AUD 320m (USD 225m) buyout offer from Skip Capital and Stonepeak Partners, but it is open to further advances.
Potentia agrees $623m exit from Australia's Micromine
Australia’s Potentia Capital has agreed to exit its position in local mining software provider Micromine to UK-based industrial software player AspenTech in a deal worth AUD 900m (USD 623m).
Apax buys Australia automotive auctions platform
Apax Partners has acquired a majority position in Australian vehicles and industrial equipment marketplace Pickles Auctions.
Australian compostable cling film business gets $17m Series A
Great Wrap, an Australia-based start-up that manufacturers compostable cling film from food waste, has raised AUD 24m (USD 17m) in Series A funding.
Australia's mx51 secures $22.5m Series B
Mx51, an Australia-based payments technology platform that emerged as a partnership with Westpac, has raised AUD 32.5m (USD 22.4m) in Series B funding.
Australia's Fortitude exits Shopper Media to Woolworths
Australian grocery giant Woolworths has agreed to buy Shopper Media Group, an out-of-home digital advertising business with 2,000 screens across more than 400 shopping centres, for approximately AUD 150m (USD 102m).
ANZ withdraws from MYOB acquisition talks
Australia and New Zealand Banking Group (ANZ) has ended its pursuit of KKR-owned Australian accounting software provider MYOB just days after confirming talks over a potential acquisition.
Australia customer reviews specialist gets $26m Series A
Okendo, an Australia-founded customer review platform for e-commerce brands, has received USD 26m in Series A funding led by US venture capital firm Base10 Partners.
Australia retail AI player raises $30m
Tiger Global Management has led a USD 30m Series B round for Australia’s Hivery, an artificial intelligence (AI) developer for the retail industry.
KKR explores sale of Australia's MYOB to ANZ
Australia and New Zealand Banking Group (ANZ) has confirmed it is in negotiations with KKR over the potential acquisition of Australia-based accounting software provider MYOB.
Brett Sutton to leave role as CVC's Australia chair
Brett Sutton, a former partner at Affinity Equity Partners who was recruited by CVC Capital Partners last August to oversee the reestablishment of its Australia presence, will leave the firm at the end of the year.
Quadrant exits Australia underwear brand to Swedish strategic
Quadrant Private Equity has exited Australian hygiene apparel brand Modibodi to Swedish strategic Essity for AUD 140m (USD 96m).
Accel-KKR targets Australia-listed SaaS player Damstra
Damstra Technology, a listed Australian software-as-a-service (SaaS) provider specialising in worker safety and risk management, has received an unsolicited buyout proposal from Accel-KKR.
Blackstone backs Australia, US clean commodities platform
The Blackstone Group has led a USD 400m investment in Xpansiv, an Australia and US-based marketplace for trading clean commodities such as carbon offsets, renewable energy credits (RECs), and low-carbon fuels.
Australian start-up wins backing for spider venom drug
Infensa Bioscience, a newly established Brisbane-based drug developer, has raised AUD 23m (USD 15.6m) in funding to support the licensing of a nascent treatment that uses spider venom to mitigate heart attacks and strokes.
Deal focus: CDH plays Asia wellness card
CDH Investments turned The Better Health Company from a New Zealand-only player into a brand with regional recognition. COVID-19 proved a minor obstacle to an ultimately successful trade sale
Australia tech: Valuation conundrum
Valuation adjustments and down rounds are expected to proliferate in Australia’s technology sector in the next 12 months. Investors are busy scrutinising business models for signs of vulnerability
Future Fund promotes private equity head to deputy CIO
Alicia Gregory, head of private equity at Australia’s Future Fund, has been promoted to deputy CIO with responsibility for private markets.
